[CAS NO. 1802326-66-4]  JNJ 63533054

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1802326-66-4]

Catalog
SLK-S6425
Brand
Selleck
CAS
1802326-66-4

DESCRIPTION [1802326-66-4]

Overview

MDLMFCD29924732
Molecular Weight316.78
Molecular FormulaC17H17ClN2O2
SMILESO=C(NCC(N[C@H](C1=CC=CC=C1)C)=O)C2=CC=CC(Cl)=C2

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM3.1568 mL15.7838 mL31.5676 mL
5 mM0.6314 mL3.1568 mL6.3135 mL
10 mM0.3157 mL1.5784 mL3.1568 mL
50 mM0.0631 mL0.3157 mL0.6314 mL

Description

JNJ 63533054 is a potent and selective agonist. It specifically activated human GPR139 in the calcium mobilization (EC50 = 16 ± 6 nM) and GTPγS binding (EC50 = 17 ± 4 nM) assays.

Targets

human GPR139 [1]
(Cell-free assay)
mouse GPR139 [1]
(Cell-free assay)
rat GPR13 [1]
(Cell-free assay)
0.024 μM(Ki)0.054 μM(Ki)0.075 μM(Ki)

In vitro

JNJ-63533054 specifically activates human GPR139 in the calcium mobilization (EC50 = 16 ± 6 nM) and GTPγS binding (EC50 = 17 ± 4 nM) assays. JNJ-63533054 also activates the rat and mouse GPR139 receptor with similar potency (rat EC50 = 63 ± 24 nM, mouse EC50 = 28 ± 7 nM).